Prof. Dr. Yasmina Mohammed Abd-Elhakim is a Professor in the Forensic Medicine and Toxicology Department in the Faculty of Veterinary Medicine, Zagazig University, Egypt. Her major area of expertise is the use of eco-friendly mitigation strategies to combat the hazards of environmental pollutants. Additionally, she has a special interest in the therapeutic uses of arthropods venoms, particularly in neurodegenerative diseases and cancer. She has 60 papers in prestigious international journals and 2 book chapters, h-index 19, and more than 1000 citations based on the Scopus database. She reviewed about 870 manuscripts for highly impacted journals in the field of toxicology and environmental pollution based on the Publon database. She has been included in the editorial board of several highly impacted international journals. She received various awards including The Egyptian State Encouragement Award in "Agricultural sciences" in 2019, the Publons peer reviewer award as a Top Reviewers for Pharmacology & Toxicology in 2018 and 2019, and the international publication's award from Zagazig University (2015-2019).
Dr. Pragyan Acharya is an Associate Professor in the Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India. The major interests of her laboratory is in understand immune dysregulation in liver diseases and understanding the interaction of the immune system in tissue injury and infection. Towards this, she combines studies on clinical samples, in vitro cultures and animal models of liver disease. She is specifically studying non-alcoholic fatty liver disease (NAFLD) and acute-on-chronic liver failure (ACLF) using proteomics and cell biological approaches. Work carried out in her laboratory has led to the identification of the importance of the CD177+ neutrophil sub-population in ACLF and its association with patient outcomes.
Head of the Graduate School at St George's, University of London.
Dr. Nitin Amdare is a Staff Scientist in the Department of Microbiology and Immunology at the Albert Einstein College of Medicine. His primary research interest is to contribute significantly to identifying and characterizing the specific human auto-antigen peptides of potential clinical relevance recognized by HLA-restricted islet-infiltrating CD8 T cells, which could facilitate the development of antigen-specific strategies that identify those most likely to be therapeutic targets and markers of pathogenic autoimmunity.
President of the Israel Academy of Sciences & Humanities. Former VP of the Weizmann Institute of Science. Significant contributions to vaccine development, cancer research & parasitic diseases. Has served as President of EFIS and Secretary-General of the IUIS. Awards include the Robert Koch Prize in Medical Sciences, Spain’s Diaz Memorial Prize, France's Legion of Honor, the Hadassah World Organization's Women of Distinction Award, the Wolf Prize for Medicine, the Rothschild Prize for Biology.
I am currently working as Asscociate research scientist at Yale University. Previously I worked as Postdoctoral fellow at National Institutes of Health, USA. My current work is on infectious diseases such as malaria, tuberculosis, Lyme, Anthrax. In my project, I study immune correlates of protection to malaria. I have about 10 years of post-PhD experience in Global health, Immunology and Microbiology. I did my PhD from CSIR-Institute of Genomics and Integrative Biology, Delhi, India working on bacterial pathogens M. tuberculosis and other gram-positive bacterial pathogens. I worked as Vaccine Research Innovation awardee at Translational Health Science and Technology Institute in India.
I have 26 publications in International peer-reviewed journals and have published 4 Book chapters. My current h-index is 18. In the recent past, I have served as reviewer for Frontiers Journal, MDPI journals, Nature press journals, Medicine, Pathogen and vectors, BMC Microbiology, Archives of Microbiology, Journal of Antimicrobial Chemotherapy, and Indian Journal of Microbiology.
Professor of Immunology and Basic Oncology; Center for Molecular Medicine and Stem Cells Research, Faculty of Medical Sciences, University of Kragujevac.
Professor of Genetics and Deputy Head of the Department of Genetics, Ecology and Evolution. He is a member of the Brazilian Academy of Sciences and is a Knight of the National Order of Scientific Merit of the Brazilian Ministry of Science, Technology and Innovation. Researcher 1A of the National Council for Scientific and Technological Development (CNPq) which is the highest position.
Professor of Thoracic Medicine at the National Heart and Lung Institute, Head of Respiratory Medicine at Imperial College & Honorary Consultant Physician at Royal Brompton Hospital, London. Has been the most highly cited clinical scientist in Europe & the most highly cited respiratory researcher in the world over the last 20 years. Elected a Fellow of the Royal Society in 2007. Currently a member of the Scientific Committee of the WHO/NIH global guidelines on asthma (GINA) and COPD (GOLD).
Barnes is the author of over 1,000 publications in peer reviewed journals. He has edited or co-edited over 50 books on asthma, COPD and respiratory pharmacology.
He has been received honorary degrees from the Universities of Ferrara (Italy), Athens (Greece), Tampere (Finland), Leuven (Belgium) and Maastricht (Netherlands). He co-founded an Imperial spin-out company RespiVert, which was acquired by Johnson & Johnson and has developed novel inhaled treatments for COPD and severe asthma.
Prof. Becker is heading the Department of Translational Oncology at the Westdeutsches Tumorzentrum in Essen with a focus on skin cancer research.
Jürgen C. Becker received his medical degree from the Medical School Hannover for his work on the immune regulatory capacity of natural killer cells on the adaptive immune system. After finishing medical school he was first trained in Dermatology at the University of Würzburg and then as well in Tumor Immunology at the Scripps Research Institute, La Jolla, and the Danish Cancer Society, Copenhagen. For his characterization of the impact of therapeutic interventions on the adaptive immune responses against melanoma in preclinical models he received the PhD in Immunology. In 2003 he became full professor for Dermato-Oncology in Würzburg, where he coordinated a Clinical Research Group focusing on the tumor microenvironment. In 2010, he was appointed as director of General Dermatology at the Medical University of Graz. There, in parallel to his clinical duties, he successfully attracted the FP7 EU-project IMMOMEC (IMmune MOdulating strategies for treatment of MErkel cell Carcinoma, www.immomec.eu) and became deputy speaker of the graduate training program DK-MOLIN (Doktoratskolleg MOLecular fundamentals of INflammation, www.medunigraz.at/DK-MOLIN/).
Regental Professor and Director of the Center for the Genetics of Host Defense at the UT Southwestern Medical Center in Dallas, Texas. Member of the National Academy of Sciences and the Institute of Medicine. Recipient of many awards, including the 2011 Nobel Prize for Medicine; the 2011 Shaw Prize; the 2009 Will Rogers Institute Annual Prize; the 2009 Albany Medical Center Prize; the 2007 Balzan Prize and the 2004 Robert Koch Prize. (Photo by Brian Coats for UT Southwestern Med Ctr)
Dunja Bruder did her PhD thesis in immunology focussing on T cell responses to bacterial toxins (1996-1999) followed by a postdoc in the field of mucosal immunology at the HZI in Braunschweig (2000-2006). After several scientific stays abroad (Harvard Medical School; Yale University School of Medicine) she became head of the research group “Immune Regulation” at the HZI (2006). In addition, since 2011 Dunja Bruder is Professor for "Infection Immunology" at the University Hospital in Magdeburg.